MedPath
HSA Approval

EXODIN TABLET 180MG

SIN14591P

EXODIN TABLET 180MG

EXODIN TABLET 180MG

August 18, 2014

PHARMAZEN MEDICALS PTE LTD

PHARMAZEN MEDICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAZEN MEDICALS PTE LTD
Licence HolderPHARMAZEN MEDICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R06AX26

fexofenadine

Manufacturer Information

PHARMAZEN MEDICALS PTE LTD

Medreich Limited

Active Ingredients

Fexofenadine Hydrochloride

180mg

Fexofenadine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EXODIN TABLET 180MG - HSA Approval | MedPath